| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Benzadamyin | 3-Dimethylaminopropyl-2-benzylaminobenzoate (Free Base) | VE009570 | View CAS 87453-76-7 |
| Benzadamyin | 5-Benzyl Benzydamine (Free Base) | VE009571 | View CAS 1797879-37-8 |
Benzadamyin Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Benzadamyin | 3-Dimethylaminopropyl-2-benzylaminobenzoate (Free Base) | VE009570 | View CAS 87453-76-7 |
| Benzadamyin | 5-Benzyl Benzydamine (Free Base) | VE009571 | View CAS 1797879-37-8 |
[rfq_list]
| Catalogue No. | VE009571 |
| CAS No. | 1797879-37-8 |
| Molecular Formula | C26H29N3O |
| Molecular Weight | 399.54 g/mol |
| Parent drug | Benzadamyin |
| IUPAC Name | 3-(1, 5-Dibenzyl-1H-indazol-3-yl)oxypropyldimethylamine |
| Synonyms | N/A |
| References | Roopashri, G., Jayanthi, K., & Guruprasad, R. (2011). Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: A drug trail. Contemporary Clinical Dentistry, 2(1), 8. https://doi.org/10.4103/0976-237x.79292 |
| Status | In-stock |
| ListName | 5-Benzyl Benzydamine (Free Base) |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
